FPS One of my most anticipated shooters, which looks like Demon's Souls in the Doom engine, finally has a release date right around the corner Action Peak dev's next co-op game—Crashout Crew—is like ...
Vertex Pharmaceuticals has hit a snag in its efforts to follow up non-opioid pain reliever Journavx (suzetrigine). The Boston-based Big Biotech’s sodium channel inhibitor VX-993 failed to outpace ...
Vertex Pharmaceuticals stock (NASDAQ: VRTX) is trending higher after the U.S. FDA approved Journavx – an oral non-opioid pain medication. This is a big win for Vertex, given that Journavx can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback